Showing 801-810 of 1097 results for "".
- iCRYO to Bring BTL Devices to Franchiseshttps://modernaesthetics.com/news/icryo-to-bring-btl-devices-to-franchises/2473353/iCRYO is partnering with BTL Industries to bring BTL’s suite of devices to their franchises. “We are going into a multi-year purchasing agreement to onboard several hundred devices over that time period. We are working on launching our "EMsuite" within the iC
- Merz Aesthetics, NWSL’s North Carolina Courage Grow Partnershiphttps://modernaesthetics.com/news/merz-aesthetics-nwsls-north-carolina-courage-partner-to-fuel-confidence-on-and-off-the-field/2473352/Merz Aesthetics is expanding its sponsorship of the North Carolina Courage, two-time champions of the National Women’s Soccer League (NWSL). “This partnership is so meaningful for us at Merz Aesthetics,” says Patrick Urban, North America President, in
- Game Change: Galderma Launches FACE by Galdermahttps://modernaesthetics.com/news/galderma-launches-face-by-galderma/2473349/Galderma is launching FACE by Galderma, an app that simulates the results of injectable treatments in real time using digital facial assessment. The technology was unveiled at the International Master Course on Aging Science (IMCAS) World Congress 2023 in Paris. FACE by Galder
- Study: Jeuveau “Extra-Strength” Dose Shows Lasting Resultshttps://modernaesthetics.com/news/evolus-to-present-phase-2-interim-data-from-jeuveau-extra-strength-dose-for-extended-duration-study-at-2023-imcas-world-congress/2473346/Evolus' Jeuveau Extra-Strength achieved one-point improvement on the Glabellar Lines Scale with the duration of effect lasting 26 weeks, representing a prolonged 6-month performance, the Company reports. The extra-strength glabellar line study is a multicenter, double
- Apyx Medical Launches #ThisIsMe Renuvion Campaignhttps://modernaesthetics.com/news/apyx-medical-launches-thisisme-renuvion-campaign/2473341/Apyx Medical Corporation is rolling out its first-ever direct-to-consumer brand campaign for Renuvion, a proprietary helium plasma and radiofrequency technology. The #ThisIsMe campaign is aimed at U.S. consumers who are interested in a minimally invasive procedu
- Endo Pulls Qwo from Markethttps://modernaesthetics.com/news/endo-pulls-qwo-from-market/2473339/Endo International plc is ceasing the production and sale of Endo Aesthetics' Qwo (collagenase clostridium histolyticum-aaes) in light of market concerns about the extent and variability of bruising following initial treatment as well as the potential for prolonged skin discoloratio
- Allergan Aesthetics Celebrates Fourth Annual BOTOX Cosmetic Dayhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-fourth-annual-botox-cosmetic-day/2473322/Allergan Aesthetics is inviting people across the country to take a "Moment for You" on Wednesday, Nov. 16, 2022 to celebrate the biggest event of the year for Botox Cosmetic. For this year's celebration, BOTOX Cosmetic is sharing two exclusive offers availa
- Teyana Taylor Tapped as New Xeomin Brand Partnerhttps://modernaesthetics.com/news/teyana-taylor-tapped-as-new-xeomin-brand-partner/2473321/Xeomin, an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t. “I always strive to understand the ingredients in any product I’m using and listen to trusted so
- New from Alastin: Meet A-LUMINATE BRIGHTENING SERUMhttps://modernaesthetics.com/news/new-from-alastin-meet-a-luminate-brightening-serum/2473316/Galderma’s ALASTIN Skincare is rolling out A-LUMINATE BRIGHTENING SERUM to help reduce the appearance of surface pigmentation without any harsh, irritating ingredients. A-LUMINATE BRIGHTENING SERUM contains a multifaceted blend of peptides, antioxidants, and targeted in
- ASDS News: Patients Love Galderma's Investigational Liquid Botulinum Toxinhttps://modernaesthetics.com/news/asds-news-patients-love-galdermas-investigational-liquid-botulinum-toxin/2473312/Galderma's investigational ready-to-use liquid botulinum toxin RelabotulinumtoxinA scored high patient satisfaction and psychological well-being ratings for the treatment of glabellar lines and lateral canthal lines in addition to previously reported safety and efficacy, according to pre